Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : REPR - REPRO MED SYSTEMS INC -- Ignore unavailable to you. Want to Upgrade?

To: brogan who wrote (9)	1/13/2000 5:21:00 PM
From: SgtPepper	Read Replies (1) \| Respond to of 37

I think I just heard the wake-up bell! Repro-Med Systems Announces Signing National Purchasing Agreement With Child Health Corporation of America CHESTER, N.Y., Jan. 13 /PRNewswire/ -- Repro-Med Systems, Inc. (OTC Bulletin Board: REPR) announced that it has signed a group purchasing agreement with Child Health Corporation of America for its Freedom60 Syringe Infusion System. CHCA is a cooperative and business alliance of 38 children's hospitals which represents $4.5 billion in annual revenues, has over 61,000 hospital employees and 19,000 pediatricians and pediatric specialists. The agreement calls for CHCA to assist RMS to market the Freedom60 to its members through December, 2002. Andy Sealfon, President of Repro-Med, said, "While we have several individual members of this hospital group currently using the Freedom60, CHCA represents the first major hospital group that has endorsed the Freedom60 at the national level. It's now our job to introduce each member hosptial to the tremendous cost savings and outstanding performance of the Freedom60. Based on our current users, we believe the potential exists for each facility to acquire in excess of 75 pumps per location." Sealfon added that, "the Freedom60 represents one of those breakthrough products which provides unprecedented performance at a cost equal to or less than a gravity drip infusion. In these days of diminishing insurance reimbursement, the Freedom60 enables a safe reliable-and for children most importantly-portable infusion to be in reach of every patient." The Freedom60 Syringe Infusion System consists of a non-electric, portable, low cost device which creates a safe constant pressure infusion. The Freedom60 uses standard 60ml syringes, and dedicated tubing sets to control the flow rates. The Freedom60 has been designed to operate to in excess of 4,000 cycles making it one of the lowest cost per use devices on the market. For further information please visit the Company's web site at repro-med.com or call 800-624-9600. This press release contains certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) and information relating to Repro-Med Systems, Inc. that are based on the beliefs of the management of Repro-Med Systems, Inc. as well as assumptions made by and information currently available to the management of Repro-Med Systems, Inc. The Company's actual results may vary materially from the forward-looking statements made in this report due to important factors such as: recent operating losses, uncertainties associated with future operating results; unpredictability related to Food and Drug Administration regulations, introduction of competitive products, limited liquidity; reimbursement related risks; government regulation of the home health care industry; success of the research and development effort, market acceptance of FREEDOM60, availability of sufficient capital to continue operations and dependence on key personnel. When used in this press release, the words "estimate," "project," "believe," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect the current views of Repro-Med Systems, Inc. with respect to future events based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Repro-Med does not undertake any obligation to release publicly any revision to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. SOURCE Repro-Med Systems, Inc. /CONTACT: Andy Sealfon of Repro-Med Systems, Inc., 800-624-9600/ /Web site: repro-med.com Jan-13-2000 16:37 GMT Symbols: US;REPR Source PRN PR NewsWire Categories: NWR/NY NWI/MTC NWI/BIO NWI/HEA NWS/LIC